Figure 3From: Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer Transcriptomic screen identifies three markers as a prognostic panel in breast cancer. Our three-marker model is associated with RFS at mRNA level using a meta-analysis of 10 independent transcriptomic datasets.Back to article page